At a glance
ClinicalIndex Comparison RecordN/ACompleted· 50 enrolled
Drug / intervention
Complete SE Iliac Stent +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Medtronic Complete® Self-Expanding Stent and Stent Delivery System Registry: a Non-randomized Prospective, Multicenter, Consecutive Registry
In Brief
A clinical study evaluating Complete SE Iliac Stent for Peripheral Vascular Disease. Completed, enrolled 50 participants across 2 sites.
Detailed Summary
The purpose of this study is to show if a new delivery system with a modified stent is safe in treating occluded iliac arteries in patients with peripheral vascular disease. The modified Complete SE delivery system is hypothesized to assist physicians with more accurate stent placement reducing the likelihood of stent 'jumping' seen with the use of many self-expanding stent systems.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPeripheral Vascular Disease
CountriesUnited States
CollaboratorsMedtronic
Timeline
N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartNov 2007
First PostedAug 2008
Primary CompletionFeb 2009
Study CompletionAug 2012
TodayJul 2026
First PostedAug 8, 2008
Enrollment StartNov 1, 2007
Primary CompletionFeb 1, 2009
Study CompletionAug 1, 2012
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 17.9 years ago
Interventions
Complete SE Iliac Stentdevice
Iliac stenting
Complete SE Iliac Stentdevice
Self-expanding stent